2535 Results
1

UC grant will increase training of clinicians to work with at-risk youth

October 19, 2021

A nearly $2 million grant to the University of Cincinnati’s College of Allied Health Sciences will establish the UC Bear-CAT Fellowship Program. The goal of the project is to increase the number of adequately prepared graduate-level behavioral health clinicians entering and continuing practice with at-risk children, adolescents and transitional-age youth (ages 18-24) in the Greater Cincinnati region.

5

How UC pharmacy gives back, makes urban impact

September 20, 2021

Bethanne Brown, associate professor of pharmacy practice and residency director in UC’s James L. Winkle College of Pharmacy, sees pharmacy outreach as a privilege, and is instrumental in making a difference for the underprivileged populations in the Tristate. Her impact as director of UC's pharmacy residency program, in collaboration with the St. Vincent de Paul Charitable Pharmacy, helps provide free care and prescribed medications to underserved communities in the region.

7

UC renews cooperative agreement with U.S. Air Force

November 9, 2021

The University of Cincinnati and the U.S. Air Force have renewed their cooperative agreement that could mean up to $49 million in research funds. This is the second renewal of the cooperative agreement dating back to 2010.

8

UC researcher examines impact of mass incarceration on youth, family health

March 2, 2022

Samantha Boch of the University of Cincinnati College of Nursing, having worked as a prison nurse while working to get her doctorate is now devoting her time to research the impact of mass incarceration on child and family health. She was involved with two research papers that got published in 2021.

9

UC joins nationwide clinical study to test medications for mild-to-moderate COVID-19

February 15, 2022

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.